Trailing-twelve-month (TTM) revenue is $466,302 with a year-over-year growth of (92.11%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $106,592 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-17 |
| Q4 FY2025Period ended 2025-12-31 | $51,761 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-01 |
| Q1 FY2026Period ended 2026-03-31 | $156,009 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-18 |
| Q2 FY2026Period ended 2026-06-30 | $151,940 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14 |
| TTM revenue | $466,302 |
Current P/S: $2,669,705 market capitalization ÷ $466,302 TTM revenue = 5.73x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:15:27.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $151940.00.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:17:14.231Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| Product | N/A | N/A | N/A | $9M | $2M |
| Shipping and Handling | N/A | N/A | N/A | $186,165 | $193,998 |
$466,302
$466,302
(92.11%)
vs. $5.91M a year ago (TTM)
(46.70%)
5 Year compound annual growth rate
1 Year
(92.11%)
3 Year
(64.14%)
5 Year
(46.70%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.93M | ($7.36M) | (79.24%) |
| 2024 | $9.29M | ($637,069) | (6.42%) |
| 2023 | $9.93M | ($474,119) | (4.56%) |
| 2022 | $10.40M | ($733,000) | (6.58%) |
| 2021 | $11.14M | +$2.95M | +36.06% |
| 2020 |
TTM Growth
(92.11%)
3-Year CAGR
(64.14%)
5-Year CAGR
(46.70%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 24 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T19:17:14.231Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-12-12.
| Shipping and other | $191,048 | $445,721 | $566,463 | N/A | N/A |
|---|
| Specimens | $11M | $10M | $9M | N/A | N/A |
|---|
| $8.18M |
| +$3.89M |
| +90.40% |
| 2019 | $4.30M | ($96,468) | (2.20%) |
